Basis: Current FMP quote-based enterprise value / four-quarter operating income. Source: stored company filings and market data; unavailable inputs remain N/A.
The EV/EBIT ratio is N/A as of 2026-10-06T12:45:58.974Z.
Calculation as of: 2026-10-06T12:45:58.974Z.
Quote observation: 2026-10-05T20:00:01.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: aa9bc7f9cefff507f8a4fe626b62717351a0ace1a98d881cea9fd3b4864bb5d1
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EV/EBIT RATIO
N/A
Clover Health Investments, Corp.
Market Cap
$2.43B
EV/EBIT Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$2.34B
EV/EBIT Ratio
11.14x
TTM Avg
17.19x
3Y Avg
119.55x
5Y Avg
119.55x
Market Cap
$2.51B
EV/EBIT Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$2.31B
EV/EBIT Ratio
8.30x
TTM Avg
7.33x
3Y Avg
8.48x
5Y Avg
15.70x
Market Cap
$2.17B
EV/EBIT Ratio
N/A
TTM Avg
4584.86x
3Y Avg
4584.86x
5Y Avg
4584.86x
Market Cap
$2.69B
EV/EBIT Ratio
15.00x
TTM Avg
12.41x
3Y Avg
11.52x
5Y Avg
10.90x
Market Cap
$2.69B
EV/EBIT Ratio
14.17x
TTM Avg
12.70x
3Y Avg
46.55x
5Y Avg
42.04x
| NAME | MARKET CAP | EV/EBIT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Clover Health Investments, Corp. (CLOV) | $2.43B | N/A | N/A | N/A | N/A |
| ADMA Biologics, Inc. (ADMA)vs › | $2.34B | 11.14x | 17.19x | 119.55x | 119.55x |
| Recursion Pharmaceuticals, Inc. (RXRX)vs › | $2.51B | N/A | N/A | N/A | N/A |
| Harmony Biosciences Holdings, Inc. (HRMY)vs › | $2.31B | 8.30x | 7.33x | 8.48x | 15.70x |
| Beam Therapeutics Inc. (BEAM)vs › | $2.64B | N/A | N/A | N/A | N/A |
| Alamar Biosciences, Inc. (ALMR)vs › | $2.64B | N/A | N/A | N/A | N/A |
| Celldex Therapeutics, Inc. (CLDX)vs › | $2.17B | N/A | 4584.86x | 4584.86x | 4584.86x |
| Acadia Healthcare Company, Inc. (ACHC)vs › | $2.69B | 15.00x | 12.41x | 11.52x | 10.90x |
| Aveanna Healthcare Holdings Inc. (AVAH)vs › | $2.69B | 14.17x | 12.70x | 46.55x | 42.04x |
| Addus HomeCare Corporation (ADUS)vs › | $2.11B | 14.29x | 15.46x | 18.22x | 20.56x |
EV/EBIT = Enterprise Value / EBIT (TTM)
Enterprise value to EBIT compares total company value to operating earnings, accounting for depreciation unlike EV/EBITDA.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
